MktsMarkets

Journey Medical Corporation
NASDAQ: DERMKey statistics
DERM News
Stories mentioning DERM from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 15,921 | 16,066 | 17,025 | 15,009 | 13,139 | 12,620 | 14,629 | 14,855 |
| Cost of Goods Sold | 6,218 | 4,790 | 2,237 | 5,285 | 6,541 | |||
| Gross Profit | 9,703 | 8,349 | 10,383 | 9,344 | 8,314 | |||
| Operating Expenses | ||||||||
| Research & Development | 287.00 | 39.00 | 218.00 | 842.00 | 913.00 | |||
| Sales General & Admin | 10,109 | 9,863 | 12,054 | 11,882 | 10,569 | 10,060 | 11,396 | 10,328 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (1,492) | (443.00) | (1,529) | (2,876) | (3,324) | 2,234 | (2,894) | (2,927) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (2,230) | (1,247) | (2,315) | (3,736) | (4,073) | 1,582 | (2,390) | (3,361) |
| Tax Provision | 60.00 | |||||||
| Net Income (Loss) | (2,230) | (1,247) | (2,315) | (3,796) | (4,073) | 1,521 | (2,390) | (3,361) |
| Earnings Per Share (Basic) | (0.08) | (0.05) | (0.09) | (0.16) | (0.18) | 0.07 | (0.12) | (0.17) |
| Earnings Per Share (Diluted) | (0.08) | (0.05) | (0.09) | (0.16) | (0.18) | 0.07 | (0.12) | (0.17) |
| Weighted Average Shares Outstanding (Basic) | 27,305 | 24,498 | 24,959 | 23,291 | 22,611 | 20,431 | 20,538 | 19,994 |
| Weighted Average Shares Outstanding (Diluted) | 27,305 | 24,498 | 24,959 | 23,291 | 22,611 | 20,431 | 20,538 | 19,994 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About DERM
Journey Medical Corporation (NASDAQ: DERM) is a stock listed on the Nasdaq Stock Market under the ticker symbol DERM. It last traded at $3.69 (Nov 18, 2026, 4:00 PM ET), down 5.4% on the day. That gives Journey Medical a market capitalisation of $110.1M.
Over the past 52 weeks DERM has traded between $3.40 and $9.55.
Revenue for the quarter ended Mar 31, 2026 was $15.9M; a net loss of $2.2M. Revenue was up 21.2% from $13.1M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $15.9M | -$2.2M | -14.0% |
| Dec 31, 2025 | $16.1M | -$1.2M | -7.8% |
| Sep 30, 2025 | $17.0M | -$2.3M | -13.6% |
| Jun 30, 2025 | $15.0M | -$3.8M | -25.3% |
From Journey Medical’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…